Inventor · disambiguated record
Alexander Berthold Hendrik Bakker
Also filed as: BAKKER ALEXANDER B H · BAKKER ALEXANDER BERTHOLD H · BAKKER ALEXANDER BERTHOLD HENDRIK · BAKKER ALEXANDER BERTHOLD HENRIK
19 granted patents·10 pending applications·446 citations·filing 2003–2024
95Inventor score
Top patents by PatentIndex Score
29 records- 0196US12139548B2Antibody that binds ErbB-2 and ErbB-3MERUS NV·Filed 2022·Granted Nov 12, 2024·4 cites·20 claims
- 0296US7740852B2Binding molecules capable of neutralizing rabies virus and uses thereofCRUCELL HOLLAND BV·Filed 2007·Granted Jun 22, 2010·46 cites·5 claims
- 0396US7550140B2Antibody to the human OX40 receptorCRUCELL HOLLAND BV·Filed 2003·Granted Jun 23, 2009·173 cites·8 claims
- 0494US8133983B2Agonistic binding molecules to the human OX40 receptorBAKKER ALEXANDER BERTHOLD HENDRIK·Filed 2009·Granted Mar 13, 2012·85 cites·13 claims
- 0593US8148497B2Binding molecules capable of neutralizing rabies virus and uses thereofBAKKER ALEXANDER BERTHOLD HENDRIK·Filed 2009·Granted Apr 3, 2012·27 cites·11 claims
- 0693US7579446B2Binding molecules capable of neutralizing rabies virus and uses thereofCRUCELL HOLLAND BV·Filed 2006·Granted Aug 25, 2009·50 cites·27 claims
- 0792US9914777B2Human CD3 binding antibodyMERUS NV·Filed 2016·Granted Mar 13, 2018·11 cites·18 claims
- 0890US11279770B2Antibody that binds ErbB-2 and ErbB-3MERUS NV·Filed 2015·Granted Mar 22, 2022·7 cites·17 claims
- 0989US10358492B2Bispecific IgG antibodies as T cell engagersMERUS NV·Filed 2013·Granted Jul 23, 2019·11 cites·30 claims
- 1088US10266593B2Human CD3 binding antibodyMERUS NV·Filed 2018·Granted Apr 23, 2019·6 cites·19 claims
- 1186US7959922B2Liquid anti-rabies antibody formulationsCRUCELL HOLLAND BV·Filed 2007·Granted Jun 14, 2011·12 cites·18 claims
- 1285US7741443B2Binding molecules for the treatment of myeloid cell malignanciesCRUCELL HOLLAND BV·Filed 2005·Granted Jun 22, 2010·7 cites·16 claims
- 1383US2024158532A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2024·Application pending·0 cites
- 1481US2024158531A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2024·Application pending·0 cites
- 1581US2024109966A1Human cd3 binding antibodyMERUS NV·Filed 2023·Application pending·0 cites
- 1681US2025026823A1Bispecific igg antibodies as t cell engagersMERUS NV·Filed 2024·Application pending·0 cites
- 1778US11873338B2CLEC12AxCD3 bispecific antibodies and methods for the treatment of diseaseMERUS NV·Filed 2019·Granted Jan 16, 2024·2 cites·13 claims
- 1878US9005624B2Binding molecules capable of neutralizing rabies virus and uses thereofBAKKER ALEXANDER BERTHOLD HENDRIK·Filed 2010·Granted Apr 14, 2015·3 cites·3 claims
- 1978US2022348683A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2022·Application pending·0 cites
- 2070US8268966B2Binding molecules for the treatment of myeloid cell malignanciesVAN DEN OUDENRIJN SONJA·Filed 2009·Granted Sep 18, 2012·1 cites·3 claims
- 2169US12503509B2CLEC12AxCD3 bispecific antibodies and methods for the treatment of diseaseMERUS NV·Filed 2023·Granted Dec 23, 2025·0 cites·27 claims
- 2268US12060418B2Bispecific IgG antibodies as T cell engagersMERUS NV·Filed 2019·Granted Aug 13, 2024·0 cites·9 claims
- 2368US11739148B2Human CD3 binding antibodyMERUS NV·Filed 2019·Granted Aug 29, 2023·0 cites·25 claims
- 2464US8632985B2Binding molecules for the treatment of myeloid cell malignanciesVAN DEN OUDENRIJN SONJA·Filed 2012·Granted Jan 21, 2014·1 cites·4 claims
- 2557US2022281957A1Modified human variable domainsMERUS NV·Filed 2020·Application pending·0 cites
- 2655US2024058444A1Antibody compositionMERUS NV·Filed 2021·Application pending·0 cites
- 2753US2006263802A1Antigenic peptides of rabies virus and uses thereofCRUCELL HOLLAND BV·Filed 2006·Application pending·0 cites
- 2846US2022127375A1Producing compositions comprising two or more antibodiesMERUS NV·Filed 2020·Application pending·0 cites
- 2946US2020384084A1Use of bispecific antibody and il-15 for combination therapyMERUS NV·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →